Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat

被引:14
作者
Reyhani-Rad, Siamak [1 ]
Mahmoudi, Javad [2 ]
机构
[1] Islamic Azad Univ, Marand Branch, Dept Lab Sci, Marand, Iran
[2] Tabriz Univ Med Sci, Neurosci Res Ctr NSRC, Tabriz, Iran
关键词
Receptor; Adenosine A2A; Oxidopamine; Parkinson Disease; Rats; PARKINSONS-DISEASE; CAFFEINE; NEUROPROTECTION; COFFEE; MODEL; RISK; CONSUMPTION; CATALEPSY; SMOKING; TEA;
D O I
10.1590/S0102-865020160020000008
中图分类号
R61 [外科手术学];
学科分类号
摘要
PURPOSE: To investigate the role of adenosine A(2A) receptors on 6-OHDA-induced motor disorder in rat. METHODS: In order to induce experimental model of Parkinson's disease, 6-hydoxydopamine (8 mu g/rat) was injected unilaterally into the SNc. After three weeks as a recovery period, 6-OHDA-induced bradykinesia and balance disturbances were assessed by using beam traversal test 10, 30 and 60 minutes after intraperitoneal injections of the drugs (caffeine, SCH58261). RESULTS: The results showed that 6-OHDA (8 mu g/rat, Intra-SNc) induced motor disorders of Parkinson's disease and increased elapsed time in the beam test (p<0.001). Injection of caffeine (30 mg/kg, i.p.) and SCH58261 (2 mg/kg, i.p.) attenuated elapsed time on beam (p<0.01 and p<0.001). We showed that acute administration of caffeine and SCH 58261 can improve the 6-OHDA-induced bradykinesia and motor disturbance. CONCLUSION: Adenosine A(2A) R antagonists improve 6-OHDA-motor deficit and this effect seems to be mediated by the inhibition of A(2A) presynaptic receptors in substantia nigra pars compacta.
引用
收藏
页码:133 / 137
页数:5
相关论文
共 28 条
[1]   Astrocyte-endothelial interactions at the blood-brain barrier [J].
Abbott, NJ ;
Rönnbäck, L ;
Hansson, E .
NATURE REVIEWS NEUROSCIENCE, 2006, 7 (01) :41-53
[2]  
Alfinito PD, 2003, J NEUROSCI, V23, P10982
[3]   Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease [J].
Chen, JF ;
Xu, K ;
Petzer, JP ;
Staal, R ;
Xu, YH ;
Beilstein, M ;
Sonsalla, PK ;
Castagnoli, K ;
Castagnoli, N ;
Schwarzschild, MA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (10) :art. no.-RC143
[4]   Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation [J].
Chen, Jiang-Fan ;
Sonsalla, Patricia K. ;
Pedata, Felicita ;
Melani, Alessia ;
Domenici, Maria Rosaria ;
Popoli, Patrizia ;
Geiger, Jonathan ;
Lopes, Luisa V. ;
De Mendonca, Alexandre .
PROGRESS IN NEUROBIOLOGY, 2007, 83 (05) :310-331
[5]   Caffeine analogs: biomedical impact [J].
Daly, J. W. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2007, 64 (16) :2153-2169
[6]   Adenosine A2A receptor antagonists for Parkinson's disease -: Rationale, therapeutic potential and clinical experience [J].
Hauser, RA ;
Schwarzschild, MA .
DRUGS & AGING, 2005, 22 (06) :471-482
[7]   A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease [J].
Hernán, MA ;
Takkouche, B ;
Caamaño-Isorna, F ;
Gestal-Otero, JJ .
ANNALS OF NEUROLOGY, 2002, 52 (03) :276-284
[8]   Coffee and tea consumption and the risk of Parkinson's disease [J].
Hu, Gang ;
Bidel, Siamak ;
Jousilahti, Pekka ;
Antikainen, Riitta ;
Tuomilehto, Jaakko .
MOVEMENT DISORDERS, 2007, 22 (15) :2242-2248
[9]   Neuroinflammatory processes in Parkinson's disease [J].
Hunot, S ;
Hirsch, EC .
ANNALS OF NEUROLOGY, 2003, 53 :S49-S58
[10]  
Impagnatiello F., 2000, EMERG THER TARGETS, V4, P635, DOI [10.1517/14728222.4.5.635, DOI 10.1517/14728222.4.5.635, DOI 10.1517/14728222.4.5.635.]